Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin added to pioglitazone in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study
Year: 2009
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Authors: Richard E. Pratley, Jane E.-B. Reusch, Penny R. Fleck, Craig A. Wilson, Qais Mekki, on behalf of the Alogliptin Study 009 Group
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: American Diabetes Association
OpenAlex ID: W2086842286